Member Info for Soupdragon78

Was said more in jest… but knowing nfx stranger things can happen.

Somehow it would not surprise me if it came out that Lanstead had sold out then got 35m shares from the placing.
Coincidence that they now how just over 35m no?

:-o

No worries older

Not quite FX, it appears they bought in.... but then sold out before having to notify.

The one way we are guaranteed to find out who it is, is through the warrants. If they exercise them or in the finals, they should be named at those points.

https://www.handbook.fca.org.uk/handbook/DTR/5/8.html

“ The notification to the issuer shall be effected as soon as possible, but not later than four trading days in the case of a non-UKissuer and two trading days in all other cases, after the date on which the relevant person:

(1) learns of the acquisition or disposal or of the possibility of exercising voting rights, or on which, having regard to the circumstances, should have learned of it, regardless of the date on which the acquisition, disposal or possibility of exercising voting rights takes effect; or (2) is informed about the event mentioned in DTR 5.1.2 R (2).”

Older, the FCA rules are that they (the shareholder) have to notify the issuer (NFX) within two trading days.

The notification date of yesterday does show that if NFX have been notified of a TR1 they don't hold back informing the market.
So we can assume that the other 'insti' does not have a notifiable holding as they haven't told the company.

Could have done so yes filter.

They’d only need to have forward sold just shy of 13m to not have to notify.

There were around 30m in obvious large sells before the admission date anyway.

Looking more likely that the placing shares were forward sold. (cue a notification to prove me wrong)

At least we have chab hoovering up the 1 trades.

Wouldn’t get too hung up on that, more than likely offloaded so they can cover the warrants.

More interesting news on the way.

my bad... £157k gross raise.

Their plan is clearly to cover the testing needed to get into discussions. Then its all about a deal and what DG and JG can get.

£157 gross raise. Minor correction

The next week or two should see the returns from the inflammation biomarker studies and also the duration of action testing. This sets up the testing in three healthy donors and opening BD activity.

If you don’t have confidence in the boards ability then it’s makes more sense for you to move on.

I don’t know Fx but I would be sceptical that an MM would want to hold that amount as inventory. They’d never be able to offload them if they wished.

That would amount to 276m shares held by them (assuming an even split of 6 mm’s so 46m each) which they simply couldn’t shift if they had to. We’ve only just had volume of 250m for the year since beginning of Jan.

Why MM’s 39%?

https://simplywall.st/stocks/gb/pharmaceuticals-biotech/lse-nfx/nuformix-shares/ownership

One good thing to interpret from the raise yesterday is that it states that the money is for further work as an addition to the current ongoing work.

We know that the ongoing work is the inflammation biomarker study and duration of action.

The recent transcription of Dans directors talk interview states that they will then test on three donor lungs ‘depending on the results’ of the first two studies.

So we can interpret that they have good results in the pipeline to go for funding of the three donor lung testing.

Not related to days, its related to work being done.

Depends on the work they want doing.

Should get results from the first set of tests recently announce within the next couple of weeks.